Intramucosal-lymphatic invasion has a slight impact on lymph node metastasis in patients with early gastric cancer.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
May 2020
Historique:
received: 29 07 2019
accepted: 24 10 2019
pubmed: 20 11 2019
medline: 25 8 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

Lymphatic invasion (LI) is associated with lymph node metastasis (LNM) and a poor prognosis in patients with early gastric cancer (EGC). Although the impact of the LI volume on LNM has been described, no reports have assessed the impact of its depth on LNM. A total of 360 EGC patients with pathologically proven LI who underwent radical gastrectomy with lymphadenectomy between January 2005 and June 2018 at our institution were extracted from our database. Patients were divided into 2 groups: the mLI group, in which LI was limited to the muscularis mucosae (n = 34); and the smLI group, in which LI reached the submucosal region (n = 326). Clinicopathological features, including the LNM incidence, were compared between the groups. LNM was recognized in 3 patients (9%) in the mLI group and 101 (31%) in the smLI group (P = 0.005). In the mLI group, LNM was not recorded in any patients who met the curative criteria of ESD other than mLI. LI limited to the mucosal region does not seem to be a strong indicator for LNM. When pathological findings of an endoscopic submucosal dissection specimen show only mLI as a non-curative criterion, the probability of LNM may be very low.

Identifiants

pubmed: 31741054
doi: 10.1007/s00595-019-01913-7
pii: 10.1007/s00595-019-01913-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-489

Références

Gastric Cancer. 2017 Jul;20(4):679-689
pubmed: 27722825
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Gastric Cancer. 2018 Jul;21(4):680-688
pubmed: 29280035
Gastric Cancer. 2009;12(3):148-52
pubmed: 19890694
Br J Surg. 2015 Oct;102(11):1394-401
pubmed: 26313295
Surg Today. 2017 Feb;47(2):202-209
pubmed: 27194020
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
Ann Surg. 2007 Nov;246(5):749-53
pubmed: 17968165
Am J Gastroenterol. 2017 Jun;112(6):874-881
pubmed: 28397873
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1346-1350
pubmed: 29084076
Ann Surg Oncol. 2007 Dec;14(12):3428-34
pubmed: 17899290
J Clin Oncol. 2009 Feb 1;27(4):612-8
pubmed: 19075275
Surg Endosc. 2017 Apr;31(4):1607-1616
pubmed: 27495338
Br J Surg. 2012 Dec;99(12):1688-92
pubmed: 23023388
Surg Endosc. 2015 May;29(5):1145-55
pubmed: 25171882
Gastric Cancer. 2018 Jan;21(1):114-123
pubmed: 28224238
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Gastric Cancer. 2017 Sep;20(5):834-842
pubmed: 28205058
Tumour Biol. 2013 Apr;34(2):1005-12
pubmed: 23292920
Korean J Intern Med. 2019 Jul;34(4):785-793
pubmed: 29921044
Gastric Cancer. 2000 Dec;3(4):219-225
pubmed: 11984739

Auteurs

Shizuki Sugita (S)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Takahiro Kinoshita (T)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. takkinos@east.ncc.go.jp.

Takeshi Kuwata (T)

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan.

Masanori Tokunaga (M)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Akio Kaito (A)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Masahiro Watanabe (M)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Akiko Tonouchi (A)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Reo Sato (R)

Department of Gastric Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Masato Nagino (M)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH